No fanfare -- no "high praise for a job well done" -- nope. With a whimper, Hans Becherer's 20-year-long ride on Schering-Plough's Board of Directors, and its Compensation Committee -- just came to an end, this morning, in Chicago.
Per the SEC-filed proxy (page 6)
. . . .Becherer and Mundy are leaving the Board as of the date of the 2009 Annual Meeting of Shareholders. . . .
Mr. Becherer had been a member of Schering-Plough's board of directors since 1989.
That means he was there when the Clarinex-launch was delayed, due to FDA violations that slowed manufacturing efforts, and then when Kogan was run out -- and when ENHANCE was delayed, and most-recently when Fred announced his intention to resign effective on the closing of the proposed Merck reverse merger. He was there, through it all, paying these executives, and claiming his role as a responsible steward of the shareholders' money. I guess only his peers (and the ultimate resolution of the 2001, 2003, 2008 and 2009 series of class action lawsuits) will decide how history judges him.
No comments:
Post a Comment